Target intelligence / Profile preview

Multiple targets via adaptogenic modulation of stress response pathways

Molecular classification
Other
01

Overview

"Multiple targets via adaptogenic modulation of stress response pathways" does not refer to a single molecular target, receptor, enzyme or protein. Instead it describes the broad mechanism by which adaptogens—natural compounds typically derived from certain medicinal plants—exert their effects. Adaptogens do this by modulating numerous molecular targets across several canonical cellular signaling networks involved in the body's adaptation to physical and psychological stressors. These mechanisms include upregulation or downregulation of gene expression related to neurohormones (e.g., CRH), GPCRs (e.g., TLR9), nuclear receptors (e.g., RORA), kinases (MAPKs), phosphatases (PTPRD/PTPRR), metabolic enzymes and chaperones. The net effect is enhanced resilience through improved homeostatic control over immune function, neuroendocrine activity and cellular metabolism[1][2][3]. Because this entry refers collectively to many different molecules rather than one defined target structure with a unique name or abbreviation—and because it cannot be mapped onto any single canonical drug target—it is not considered a valid therapeutic target entity per se. > "At least 88...genes regulated by adaptogens were closely associated with adaptive stress-response signaling pathways...including neuronal signaling related to corticotropin-releasing hormone...protein kinase A...CREB; ...CXCR4,...melatonin,...MAPK,...neuroinflammation,...opioids,...renin–angiotensin,...AMPK..." [1] In summary: This entry represents an umbrella concept describing how adaptogenic substances exert pleiotropic effects on many molecular components within the body's integrated network for responding to biological stresses—not a discrete molecule/receptor suitable for structured drug-target mapping[1][2][3].

Other names
Adaptogenic modulation of stress response pathwaysAdaptogen-regulated multiple targetsStress-response pathway modulators (adaptogens)
02

Mechanism of action

Adaptogens act by modulating multiple intracellular and extracellular signaling pathways involved in the adaptive stress response. These include activation or regulation of genes and proteins related to corticotropin-releasing hormone signaling, cAMP-mediated protein kinase A/CREB pathway, MAPK pathway, neuroinflammation mediators, G-protein-coupled receptors (GPCRs), nuclear receptors like RORA, transcription factors such as FOS and FOXO6, kinases like MAPK10/MAPK13/PRKCH/ROS1/FLT1/MERTK/TTN[1][2]. They function as mild "stress mimetics," gently stimulating these pathways to improve resilience against physiological or psychological overload[4].

03

Biological functions

Regulation of adaptive homeostasisModulation of cellular and organismal defense systemsActivation of adaptive stress response signaling pathwaysSignal transductionImmune responseNeuroendocrine regulation
04

Disease associations

Aging-related disordersStress-related disordersInflammation (including chronic inflammation/inflammaging)Neurodegenerative disease (potentially)Other (broad pleiotropic effects)
05

Safety considerations

Generally considered safe at recommended doses; however,* Polypharmacology may lead to unpredictable interactions with other medications.* Lack of standardization in herbal preparations can affect safety profiles.* Potential for allergic reactions or idiosyncratic responses.
06

Interacting drugs

Adaptogens are not single drugs but a class of compounds, including extracts from plants such as Rhodiola rosea, Eleutherococcus senticosus, Withania somnifera, Rhaponticum carthamoides, Bryonia alba[1][2][3].
07

Biomarkers

No specific biomarkers for patient selection or efficacy monitoring are established; gene expression changes in key adaptive stress-response genes may serve as research biomarkers[1][2].

Beyond the preview

Go deeper on Multiple targets via adaptogenic modulation of stress response pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple targets via adaptogenic modulation of stress response pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call